Trials / Unknown
UnknownNCT03604393
Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise
Increasing Human Papillomavirus (HPV) Immunization Rates: The Rural Adolescent Vaccine Enterprise (RAVE)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22,000 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to engage rural primary care clinics and community organizations to test interventions designed to increase HPV vaccinations in both male and female patients aged 9-26 years.
Detailed description
The overarching goal of this study is to engage rural primary care clinics and community organizations to test interventions designed to increase HPV vaccinations in both male and female patients aged 9-26 years. Using a step-wedge randomized controlled trial, we will design and test the effectiveness of multi-component primary care practice-based interventions on the completion of the HPV vaccine series and will explore implementation timing in high and low functioning practices to determine how specific characteristics affect the delivery of the full series. Additionally, we will design and test the impact of a community organization-based intervention intended to educate the public about HPV and cancer risk and risk reduction via vaccination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Practice facilitation | For this intervention, ORPRN Practice Facilitators will: 1) Build practice QI capacity by addressing the five Change Concepts; 2) Train practice clinicians and staff to generate reminder lists and notices in ALERT Immunization Information System (state immunization registry); 3) Develop an HPV immunization improvement plan for each practice using PDSA cycles and workflow mapping; and 4) Facilitate community engagement surrounding HPV vaccination messaging. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2018-07-27
- Last updated
- 2022-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03604393. Inclusion in this directory is not an endorsement.